295 related articles for article (PubMed ID: 2164681)
1. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents.
Dolan ME; Moschel RC; Pegg AE
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5368-72. PubMed ID: 2164681
[TBL] [Abstract][Full Text] [Related]
2. Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents.
Dolan ME; Mitchell RB; Mummert C; Moschel RC; Pegg AE
Cancer Res; 1991 Jul; 51(13):3367-72. PubMed ID: 1647266
[TBL] [Abstract][Full Text] [Related]
3. Depletion of O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine in three-dimensional collagen cultures of normal human breast epithelial cells.
Hamdan MA; Guzman RC; Yang J; Beattie C; Mascharack P; Nandi S
Carcinogenesis; 1992 Oct; 13(10):1743-9. PubMed ID: 1423833
[TBL] [Abstract][Full Text] [Related]
4. Modulation of mammalian O6-alkylguanine-DNA alkyltransferase in vivo by O6-benzylguanine and its effect on the sensitivity of a human glioma tumor to 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea.
Dolan ME; Stine L; Mitchell RB; Moschel RC; Pegg AE
Cancer Commun; 1990; 2(11):371-7. PubMed ID: 2242301
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.
Dolan ME; Pegg AE; Dumenco LL; Moschel RC; Gerson SL
Carcinogenesis; 1991 Dec; 12(12):2305-9. PubMed ID: 1747932
[TBL] [Abstract][Full Text] [Related]
6. Effect of O6-methylguanine on DNA interstrand cross-link formation by chloroethylnitrosoureas and 2-chloroethyl(methylsulfonyl)methanesulfonate.
Dolan ME; Pegg AE; Hora NK; Erickson LC
Cancer Res; 1988 Jul; 48(13):3603-6. PubMed ID: 2837318
[TBL] [Abstract][Full Text] [Related]
7. Effect of O6-alkylguanine pretreatment on the sensitivity of human colon tumor cells to the cytotoxic effects of chloroethylating agents.
Dolan ME; Young GS; Pegg AE
Cancer Res; 1986 Sep; 46(9):4500-4. PubMed ID: 3015389
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase.
Dolan ME; Chae MY; Pegg AE; Mullen JH; Friedman HS; Moschel RC
Cancer Res; 1994 Oct; 54(19):5123-30. PubMed ID: 7923129
[TBL] [Abstract][Full Text] [Related]
9. Resistance of the human O6-alkylguanine-DNA alkyltransferase containing arginine at codon 160 to inactivation by O6-benzylguanine.
Edara S; Kanugula S; Goodtzova K; Pegg AE
Cancer Res; 1996 Dec; 56(24):5571-5. PubMed ID: 8971155
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea.
Loktionova NA; Pegg AE
Cancer Res; 1996 Apr; 56(7):1578-83. PubMed ID: 8603405
[TBL] [Abstract][Full Text] [Related]
11. Effects of inhibition of O6-alkylguanine-DNA alkyltransferase in rats on carcinogenesis by methylnitrosourea and ethylnitrosourea.
Lijinsky W; Pegg AE; Anver MR; Moschel RC
Jpn J Cancer Res; 1994 Mar; 85(3):226-30. PubMed ID: 8188519
[TBL] [Abstract][Full Text] [Related]
12. Reduction of O6-alkylguanine-DNA alkyltransferase activity in HeLa cells treated with O6-alkylguanines.
Dolan ME; Morimoto K; Pegg AE
Cancer Res; 1985 Dec; 45(12 Pt 1):6413-7. PubMed ID: 4063990
[TBL] [Abstract][Full Text] [Related]
13. Depletion of O6-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O6-methylguanine.
Dolan ME; Larkin GL; English HF; Pegg AE
Cancer Chemother Pharmacol; 1989; 25(2):103-8. PubMed ID: 2557168
[TBL] [Abstract][Full Text] [Related]
14. Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
Gerson SL; Phillips W; Kastan M; Dumenco LL; Donovan C
Blood; 1996 Sep; 88(5):1649-55. PubMed ID: 8781420
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inactivation of human O6-alkylguanine-DNA alkyltransferase by O6-benzylguanine.
Pegg AE; Boosalis M; Samson L; Moschel RC; Byers TL; Swenn K; Dolan ME
Biochemistry; 1993 Nov; 32(45):11998-2006. PubMed ID: 8218276
[TBL] [Abstract][Full Text] [Related]
16. Effect of DNA on the inactivation of O6-alkylguanine-DNA alkyltransferase by 9-substituted O6-benzylguanine derivatives.
Pegg AE; Chung L; Moschel RC
Biochem Pharmacol; 1997 May; 53(10):1559-64. PubMed ID: 9260884
[TBL] [Abstract][Full Text] [Related]
17. Expression of mammalian O6-alkylguanine-DNA alkyltransferase in a cell line sensitive to alkylating agents.
Dolan ME; Norbeck L; Clyde C; Hora NK; Erickson LC; Pegg AE
Carcinogenesis; 1989 Sep; 10(9):1613-9. PubMed ID: 2766456
[TBL] [Abstract][Full Text] [Related]
18. Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.
Gerson SL; Zborowska E; Norton K; Gordon NH; Willson JK
Biochem Pharmacol; 1993 Jan; 45(2):483-91. PubMed ID: 8435098
[TBL] [Abstract][Full Text] [Related]
19. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine.
Crone TM; Pegg AE
Cancer Res; 1993 Oct; 53(20):4750-3. PubMed ID: 8402653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
